Yixintang Pharmaceutical Group's falling share price contras...

Yixintang Pharmaceutical Group's falling share price contrasts with its EPS growth and revenue increase, hinting at past over-hype and disappointing growth. Its poor performance over the past five years suggests potential issues, yet contrarian investors may see a turnaround opportunity.